Long-term investors holding shares in the medical device manufacturer are being urged to review their legal standing. Attorneys Daniel Sadeh and Zachary Halper are spearheading the review, which aims to recover funds for the company or implement systemic changes to oversight mechanisms. The firm operates on a contingent fee basis, meaning participants face no out-of-pocket expenses for the legal evaluation.

Legal representatives emphasize that shareholder intervention remains a primary tool for enforcing accountability and transparency within publicly traded corporations. Those interested in discussing potential relief, including financial incentive awards or structural policy shifts, may contact the firm at their One World Trade Center offices. The investigation follows a history of similar litigation by the firm, which has previously targeted instances of corporate misconduct and securities fraud across international markets.